Tratamento
GLP-1 or Bariatric Surgery: Which Is the Better Choice in 2026 Losing weight is hard. Anyone who tells you otherwise probably never tried. The good news is that 2026 brought more options than ever before, and two approaches stand out from the rest: GLP-1 medications like semaglutide and tirz.
Insurance Coverage for GLP-1 Drugs in 2026: What Changed Insurance coverage for weight loss medications has always been complicated in the United States. Medicare did not cover GLP-1 drugs for obesity alone until late 2024, when a policy shift opened the door for broader coverage. Now in 202.
Understand the current status of Mounjaro and Tirzepatide in Brazil, how it differs from Ozempic, and what patients need to know about this dual-agonist therapy.
Semaglutide reduces appetite and food intake, which helps with weight loss, but eating less can also mean absorbing fewer nutrients. Here's what research shows about common deficiencies and how to work with your doctor.
Ozempic works differently in people over 60. Here's what changes in dosing, side effects, nutrition, and safety monitoring for older adults using semaglutide.
Understand why weight regain happens after stopping Ozempic and learn which patients face the highest risk of putting pounds back on.
Wondering if Ozempic keeps working indefinitely? Research reveals what happens to semaglutide's effectiveness over extended periods and what to expect.
Not all copies of semaglutida are created equal. Here's how genérico, biossimilar, and similar differ under Brazilian regulations — and why it matters for your treatment.
Hitting a weight loss plateau on Ozempic can feel discouraging, but it's often a normal part of the process. Here's what you need to know about managing these stalls while on semaglutida.
What happens after the initial weeks fade? We look at the real, everyday changes people experience with Ozempic at the 6-month mark and beyond — from food relationships to side effects that linger.
